Answers are grounded in this paper and cite their sources.
The protein kinase superfamily represents both an enormous opportunity and a unique challenge for drug discovery. Protein kinases play central roles in the cellular economy and it is well known that a large number of diseases involve aberrant protein kinase activity. This review discusses how fragment based screening strategies, such as virtual screening, NMR and high-throughput X-ray crystallography are being employed to identify new chemo-types to produce the next generation of protein kinase inhibitors.
No takes yet. Share an insight, caveat, or question.
Adrian L. Gill (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: